Trial Profile
A Comparison of the Combination of Aprepitant and Dexamethasone Versus the Combination of Ondansetron and Dexamethasone for the Prevention of Postoperative Nausea and Vomiting (PONV) in Patients Undergoing Craniotomy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 May 2022
Price :
$35
*
At a glance
- Drugs Aprepitant (Primary) ; Dexamethasone; Ondansetron
- Indications Postoperative nausea and vomiting
- Focus Therapeutic Use
- 02 Mar 2011 Primary endpoint 'Patients-with-vomiting' has not been met
- 06 Oct 2010 Actual end date (Jun 2009) added as reported by ClinicalTrials.gov.
- 06 Oct 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.